Rigetti Computing (RGTI) is down 4.48% to $18.83 as traders rotate out of high-beta quantum names and refocus on financing overhang. The key company-specific pressure is dilution risk after Rigetti disclosed it has completed sales of $350 million of common stock under its at-the-market (ATM) equity offering program, increasing near-term supply and reminding investors that capital raises remain a core part of funding the company’s long commercialization runway. (rigetti.com)

ATM programs are typically executed in the open market over time, which can weigh on shares both mechanically (more shares outstanding) and psychologically (investors price in future fundraising). Rigetti said the completed ATM leaves it with about $575 million of cash, cash equivalents and available-for-sale investments and no debt—positive for liquidity, but the immediate market reaction often centers on the cost of that balance-sheet strength. (rigetti.com)

Beyond financing, investor sentiment in quantum computing has been sensitive to policy headlines and competitive benchmark moves. One market narrative hitting the group today is concern that potential U.S. export restrictions could disrupt global supply chains and slow international sales pathways for quantum computing companies; at the same time, major-tech advances are raising performance expectations for smaller players. (tipranks.com)

Near-term, investors will be watching whether Rigetti signals any follow-on equity issuance or updates its capital strategy after finishing the $350 million ATM. On the product side, recent disclosures highlight ongoing commercialization efforts, including the April 7, 2026 announcement tied to general availability of its 108-qubit system (Cepheus-1-108Q) via its cloud platform and Amazon Braket—developments that could help offset financing concerns if they translate into bookings and recognized revenue. (br.advfn.com)